Toggle Main Menu Toggle Search

Open Access padlockePrints

Long noncoding RNA H19X is a key mediator of TGF-β-driven fibrosis

Lookup NU author(s): Professor Fiona OakleyORCiD


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


© 2020, American Society for Clinical Investigation.TGF-β is a master regulator of fibrosis, driving the differentiation of fibroblasts into apoptosis-resistant myofibroblasts and sustaining the production of extracellular matrix (ECM) components. Here, we identified the nuclear long noncoding RNA (lncRNA) H19X as a master regulator of TGF-β-driven tissue fibrosis. H19X was consistently upregulated in a wide variety of human fibrotic tissues and diseases and was strongly induced by TGF-β, particularly in fibroblasts and fibroblast-related cells. Functional experiments following H19X silencing revealed that H19X was an obligatory factor for TGF-β-induced ECM synthesis as well as differentiation and survival of ECM-producing myofibroblasts. We showed that H19X regulates DDIT4L gene expression, specifically interacting with a region upstream of the DDIT4L gene and changing the chromatin accessibility of a DDIT4L enhancer. These events resulted in transcriptional repression of DDIT4L and, in turn, in increased collagen expression and fibrosis. Our results shed light on key effectors of TGF-β-induced ECM remodeling and fibrosis. Copyright:

Publication metadata

Author(s): Pachera E, Assassi S, Salazar GA, Stellato M, Renoux F, Wunderlin A, Blyszczuk P, Lafyatis R, Kurreeman F, De Vries-Bouwstra J, Messemaker T, Feghali-Bostwick CA, Rogler G, Van Haaften WT, Dijkstra G, Oakley F, Calcagni M, Schniering J, Maurer B, Distler JHW, Kania G, Frank-Bertoncelj M, Distler O

Publication type: Article

Publication status: Published

Journal: Journal of Clinical Investigation

Year: 2020

Volume: 130

Issue: 9

Pages: 4888-4905

Print publication date: 01/09/2020

Online publication date: 30/06/2020

Acceptance date: 17/06/2020

ISSN (print): 0021-9738

ISSN (electronic): 1558-8238

Publisher: American Society for Clinical Investigation


DOI: 10.1172/JCI135439

PubMed id: 32603313


Altmetrics provided by Altmetric